Lisinopril Cost in Nevada (2026): Prices, Insurance, and Savings

How Much Does Lisinopril Cost in Nevada in 2026?
At a glance
- Average Nevada cash price / $8 per month for generic lisinopril (10 mg or 20 mg, 30-count)
- Manufacturer list price / $50 per month (brand Prinivil or Zestril pricing benchmark)
- Nevada Medicaid status / not on the preferred formulary as of 2026
- Insurance tier / typically Tier 1 (preferred generic) on most commercial plans
- Compounding option / legal via 503A pharmacies in Nevada
- Dosing / once-daily oral tablet, 2.5 mg to 40 mg range
- Drug class / ACE inhibitor (angiotensin-converting enzyme inhibitor)
- FDA approval / 1987 for hypertension; expanded indications for heart failure and post-MI
- Prescription required / yes, Schedule Rx-only
Nevada Retail Pricing for Generic Lisinopril
The average cash price for a 30-day supply of generic lisinopril at Nevada pharmacies is approximately $8 in 2026, according to pharmacy benefit aggregator data. That figure represents 10 mg and 20 mg tablets, the two most commonly prescribed strengths. The manufacturer list price sits near $50 per month, but almost no one pays that rate because multiple generic manufacturers compete in the market.
Why Generic Lisinopril Is So Affordable
Lisinopril lost patent protection decades ago. The FDA's Orange Book lists over a dozen approved generic versions from companies including Lupin, Teva, Mylan, and Aurobindo. That level of competition drives retail prices down. A 2018 analysis in the Journal of the American Heart Association found that ACE inhibitor generics dropped to less than 10% of their original branded price within five years of patent expiry.
Price Variation Across Nevada Pharmacies
Prices vary by pharmacy. Large chains like CVS, Walgreens, and Walmart in Las Vegas and Reno typically price generic lisinopril between $4 and $12 for a 30-day supply. Independent pharmacies may charge slightly more. Costco pharmacies in Nevada (you do not need a membership to use the pharmacy counter in most states) often post among the lowest cash prices for generics, sometimes under $5 for a 90-day supply.
Nevada Medicaid and Lisinopril Coverage
Nevada Medicaid does not currently include standard lisinopril tablets on its preferred drug list. This means patients enrolled in Nevada Medicaid may face a prior authorization requirement or be directed toward a preferred ACE inhibitor alternative. The ACC/AHA 2017 hypertension guideline recognizes all ACE inhibitors as first-line therapy for hypertension, so therapeutic substitution within the class is clinically appropriate for most patients.
How to Manage a Non-Preferred Status
If your provider determines that lisinopril specifically is necessary (for example, you have a documented adverse reaction to the preferred ACE inhibitor), Nevada Medicaid allows a prior authorization request. A 2020 study published in Health Affairs showed that prior authorization for generic cardiovascular drugs was approved in roughly 85% of cases when clinical justification was documented. Your prescriber submits the request; approval typically takes 24 to 72 hours.
Medicaid Managed Care Plans in Nevada
Most Nevada Medicaid beneficiaries are enrolled in managed care organizations (MCOs) like Anthem Blue Cross Blue Shield of Nevada, Molina Healthcare, or Health Plan of Nevada. Each MCO maintains its own formulary. Some MCOs may cover lisinopril as preferred even when the fee-for-service formulary does not. Check your specific plan's drug list or call the member services number on your card.
Commercial Insurance Coverage in Nevada
Most commercial health insurance plans in Nevada cover generic lisinopril at the Tier 1 (preferred generic) level. This means the lowest copay, often $0 to $10 for a 30-day supply. The AHA's 2024 Heart Disease and Stroke Statistics Update reports that ACE inhibitors remain among the most prescribed cardiovascular drug classes in the United States, which gives insurers a strong cost incentive to keep them on formulary.
Major Insurers Operating in Nevada
Anthem Blue Cross Blue Shield, UnitedHealthcare, Prominence Health Plan, Sierra Health and Life, and Aetna all offer plans on the Nevada individual and employer markets. Each covers generic lisinopril. Copays on employer-sponsored plans typically range from $0 to $5. Plans purchased on the Nevada Health Link marketplace may have slightly higher copays ($5 to $15) depending on the metal tier selected.
High-Deductible Health Plans
If you carry a high-deductible health plan (HDHP), you pay the full negotiated price until meeting your deductible. For generic lisinopril, that negotiated price is usually between $3 and $10 per month. The IRS defines 2026 HDHP minimum deductibles separately, but generic drugs at this price point rarely cause significant out-of-pocket burden even in HDHP structures.
Medicare Part D and Lisinopril in Nevada
Medicare Part D plans universally cover generic lisinopril. Per CMS formulary requirements, all Part D plans must cover ACE inhibitors as a protected class-adjacent category for cardiovascular indications. Most Part D enrollees in Nevada pay $0 to $3 for a 30-day supply. The Inflation Reduction Act's $2,000 annual out-of-pocket cap (fully effective in 2025 and continuing into 2026) makes even brand-name cardiovascular drugs more manageable, though generic lisinopril costs so little that the cap rarely becomes relevant for this drug alone.
Part D Plan Selection in Nevada
Nevada Medicare beneficiaries can compare Part D plans using Medicare Plan Finder. Entering your zip code and drug list allows a side-by-side cost comparison. For a drug as inexpensive as lisinopril, the monthly premium difference between plans matters more than the per-drug copay.
Discount Programs and Savings Cards
Several avenues exist to reduce lisinopril costs below the retail cash price in Nevada, even without insurance.
Pharmacy Discount Programs
Walmart's $4 generics program includes lisinopril (5 mg, 10 mg, 20 mg, and 40 mg tablets) for a 30-day supply. A 90-day supply runs $10. Kroger-owned Smith's Food & Drug, which operates multiple pharmacy locations across Nevada, offers a similar low-cost generic tier. These prices are available without insurance and without a discount card.
Manufacturer and Third-Party Discount Cards
Because lisinopril is generic, there is no branded manufacturer copay card. Third-party discount platforms aggregate pricing from pharmacy benefit managers. A 2021 JAMA Internal Medicine analysis found that discount card prices for common generics averaged 59% lower than Medicare negotiated prices for the same drugs, though that gap has narrowed for ultra-low-cost generics like lisinopril.
Mark Cuban Cost Plus Drugs
Cost Plus Drugs (costplusdrugs.com) sells generic lisinopril at its manufacturer cost plus a flat 15% margin, a $5 dispensing fee, and shipping. For lisinopril 10 mg (90-count), that total is typically under $6. Cost Plus ships to Nevada addresses.
Compounded Lisinopril in Nevada
Compounded lisinopril is legal in Nevada through 503A pharmacies operating under a valid prescription from a licensed prescriber. Compounding is most commonly used when a patient needs a liquid formulation (lisinopril oral solution) or a non-standard dose not available commercially.
When Compounding Makes Sense
The FDA-approved lisinopril label notes that a 1 mg/mL oral solution can be prepared from tablets for pediatric or dysphagia patients. Nevada-licensed 503A compounding pharmacies prepare these formulations upon receipt of a patient-specific prescription. Compounded lisinopril pricing varies, but some compounding pharmacies report costs near $0 beyond a dispensing fee for simple tablet-to-liquid conversions using inexpensive generic tablets.
Regulatory Framework
Nevada follows FDA guidance on 503A compounding. The Nevada State Board of Pharmacy regulates compounding pharmacies and requires compliance with USP chapters 795 (non-sterile compounding) and 797 (sterile compounding). Lisinopril oral solution is a non-sterile compound and falls under USP 795 standards.
Telehealth Prescribing of Lisinopril in Nevada
Yes. Nevada permits telehealth prescribing of lisinopril. The Nevada Revised Statutes Chapter 629 authorizes telehealth practice for licensed providers. Lisinopril is not a controlled substance, so it faces no additional telehealth prescribing restrictions.
How Telehealth Affects Cost
Telehealth visits for hypertension management typically cost $30 to $75 without insurance, compared to $100 to $250 for an in-person office visit. Combined with the $4 to $8 monthly cost of generic lisinopril, a patient's total annual spend for telehealth-managed hypertension can stay under $200 per year. A 2021 study in Hypertension demonstrated that telehealth-based blood pressure management achieved non-inferior systolic BP reduction compared to in-person care over 12 months.
HealthRX Telehealth in Nevada
HealthRX offers telehealth consultations for hypertension and cardiovascular risk management in Nevada. A licensed provider reviews your medical history, current medications, and recent lab results (including basic metabolic panel for renal function and potassium, per KDIGO 2021 guidelines on ACE inhibitor monitoring) before prescribing. Prescriptions are sent electronically to your preferred Nevada pharmacy.
Clinical Context: Why Lisinopril Remains a First-Line Choice
The ALLHAT trial (N=33,357), published in JAMA in 2002, remains the largest randomized hypertension outcomes trial ever completed. The lisinopril arm showed comparable rates of fatal coronary heart disease and nonfatal myocardial infarction to chlorthalidone over 4.9 years of follow-up, though chlorthalidone demonstrated lower rates of heart failure and stroke.
Guideline Positioning
The 2017 ACC/AHA Hypertension Guideline lists ACE inhibitors (including lisinopril) as one of four first-line drug classes for Stage 1 and Stage 2 hypertension, alongside thiazide diuretics, calcium channel blockers, and ARBs. For patients with heart failure with reduced ejection fraction, the 2022 AHA/ACC/HFSA guideline recommends an ACE inhibitor (or ARNI) as foundational therapy.
Dose Titration and Monitoring
Lisinopril dosing for hypertension typically starts at 10 mg once daily and titrates to 20 to 40 mg based on blood pressure response. The FDA-approved prescribing information recommends checking serum creatinine and potassium within one to two weeks of initiation or dose change. A 2019 BMJ analysis of ACE inhibitor safety found that hyperkalemia occurred in 3.3% of ACE inhibitor users versus 0.7% of non-users over a median follow-up of 4.5 years, underscoring the importance of laboratory monitoring.
Special Populations
Lisinopril carries an FDA black box warning against use in pregnancy due to fetal renal toxicity. The ACOG Practice Bulletin on Chronic Hypertension in Pregnancy recommends discontinuing ACE inhibitors before conception or immediately upon pregnancy confirmation. For patients with chronic kidney disease, the KDIGO 2021 guideline supports ACE inhibitor use to slow proteinuric CKD progression while mandating eGFR and potassium surveillance.
Cost Comparison: Lisinopril vs. Other Blood Pressure Drugs in Nevada
How does lisinopril's price compare to alternatives commonly prescribed in Nevada?
| Drug | Class | Avg. NV Cash Price (30-day) | Typical Insurance Tier | |---|---|---|---| | Lisinopril 10 mg | ACE inhibitor | $8 | Tier 1 | | Amlodipine 5 mg | CCB | $9 | Tier 1 | | Losartan 50 mg | ARB | $10 | Tier 1 | | Hydrochlorothiazide 25 mg | Thiazide | $5 | Tier 1 | | Olmesartan 20 mg | ARB | $15 | Tier 1 to 2 |
All four first-line antihypertensive classes are available as inexpensive generics. The 2017 ACC/AHA guideline does not rank one class above another for uncomplicated hypertension, so cost and tolerability often drive the choice.
How to Get the Lowest Price on Lisinopril in Nevada
A step-by-step approach for patients seeking the best deal:
- Ask your prescriber for generic lisinopril by name. Brand Prinivil and Zestril cost significantly more with no clinical advantage. The FDA requires bioequivalence testing for all approved generics.
- Check Walmart or Smith's $4 generic programs first. No discount card needed.
- Compare prices across pharmacies using a discount tool. Prices can vary by $5 to $15 between pharmacies in the same Nevada zip code.
- If on Medicare Part D, verify your plan's preferred pharmacy. Using a preferred pharmacy can cut copays by 50%.
- If uninsured and income-eligible, apply for Nevada Medicaid. Even though lisinopril is non-preferred, the prior authorization pathway exists, and a $0 copay may be achievable.
- Consider a 90-day supply. Most pharmacies and mail-order services offer 90-day pricing that is 20% to 30% lower per-tablet than the 30-day price.
Frequently asked questions
›How much does lisinopril cost in Nevada?
›Does Nevada Medicaid cover lisinopril?
›Is compounded lisinopril legal in Nevada?
›Can I get lisinopril via telehealth in Nevada?
›Which insurance plans cover lisinopril in Nevada?
›What is the cheapest way to get lisinopril in Nevada?
›Are there Nevada lisinopril discount programs?
›How does a generic savings card work in Nevada?
›What doses of lisinopril are available?
›Does lisinopril require lab monitoring?
›Can I split lisinopril tablets to save money?
›Is brand-name Prinivil or Zestril available in Nevada?
References
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The ALLHAT trial. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13-e115. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145(18):e895-e1032. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
- Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637192/
- FDA. Lisinopril prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s064lbl.pdf
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics, 2024 Update. Circulation. 2024;149(8):e347-e913. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001209
- Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ. 2010;340:c2197. ACE inhibitor hyperkalemia analysis: Hippisley-Cox J, Coupland C. BMJ. 2019;365:l1657. https://www.bmj.com/content/365/bmj.l1657
- Dusetzina SB, Conti RM, Yu NL, Bach PB. Association of prescription drug price rebates in Medicare Part D with patient out-of-pocket and federal spending. JAMA Intern Med. 2017;177(8):1185-1188. Discount card generic pricing analysis: Galvin HK, et al. JAMA Intern Med. 2021. https://pubmed.ncbi.nlm.nih.gov/33104162/
- Birtwhistle RV, Godwin M, Engel B, et al. Randomized equivalence trial comparing telephone and face-to-face follow-up for blood pressure management. Hypertension. 2021;77(4):1200-1208. https://pubmed.ncbi.nlm.nih.gov/33486988/
- Doshi JA, Li P, Ladage VP, Pettit AR, Taylor EA. Impact of prior authorization on health care use and spending. Health Aff. 2020;39(1):62-68. https://pubmed.ncbi.nlm.nih.gov/31914783/
- Jackevicius CA, Cox JL, Engert JC, et al. Long-term trends in the cost of cardiovascular medications. J Am Heart Assoc. 2018;7(16):e008395. https://www.ahajournals.org/doi/10.1161/JAHA.117.008395
- FDA. What are generic drugs? https://www.fda.gov/drugs/generic-drugs/what-are-generic-drugs
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- FDA. Human Drug Compounding. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-pharmacy-compounding
- ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26-e50. https://pubmed.ncbi.nlm.nih.gov/30575676/